Brief: Cue Biopharma Enters Into Open Market Sale Agreement
Oct 1 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA INC - ENTERED INTO OPEN MARKET SALE
AGREEMENT
* CUE BIOPHARMA INC - PURSUANT TO AGREEMENT CO MAY OFFER &
SELL
SHARES OF ITS COMMON STOCK, HAVING AN OFFERING PRICE OF UP TO
$80 MILLION - SEC FILING
Source text (https://bit.ly/3l0yVxg)
Further company coverage: CUE.O
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria